Meeting
2019 ASCO Quality Care Symposium
Barriers and facilitators to the implementation of routine ototoxicity screening for head and neck cancer patients.
Authors
Priya Bapat
Princess Margaret Cancer Centre Division of Medical Oncology and Hematology, Toronto, ON, Canada
Priya Bapat, Pansy Chow, Katrina Hueniken, Mary Mahler, M. Catherine Brown, Carolyn Falls, Andrew J. Hope, Aaron Richard Hansen, David Paul Goldstein, John Rutka, Doris Howell, Wei Xu, Geoffrey Liu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities
Sub Track
Access to Care
Citation
J Clin Oncol 37, 2019 (suppl 27; abstr 127)
DOI
10.1200/JCO.2019.37.27_suppl.127
Abstract #
127
Poster Bd #
K2
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Impact of statin type and intensity on cisplatin-related hearing loss.
First Author: Emilee McCullough
Poster
2017 ASCO Annual Meeting
Resource utilization in patients with head and neck cancer: Analysis of CCTG HN6 (NCT00820248).
First Author: Ketan Ghate
Poster
2012 ASCO Annual Meeting
Hearing evaluation of head and neck cancer patients (HNCP): Comparison of adverse event (AE) criteria.
First Author: A. Dimitrios Colevas
Poster
2022 ASCO Annual Meeting
The RADIO trial: Randomized assessment of cisplatin dosing interval for ototoxicity with curative concurrent chemo-radiation for locally advanced head and neck squamous cell carcinoma.
First Author: Sara Kuruvilla